References
- The Global Cancer Observatory - All Rights Reserved - March, 2021.
- Liu, X., et al., Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies. Genes Dis, 2023. 10(1): p. 151–164.
- Tuomisto, A.E., M.J. Mäkinen, and J.P. Väyrynen, Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance. World J Gastroenterol, 2019. 25(31): p. 4383–4404.
- Wall, I., et al., Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood. Cancers (Basel), 2022. 14(18).
- Shaul, M.E. and Z.G. Fridlender, Neutrophils as active regulators of the immune system in the tumor microenvironment. J Leukoc Biol, 2017. 102(2): p. 343–349.
- Kehm, R.D., et al., Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research. Int J Environ Res Public Health, 2020. 17(15).
- Ghasemzadeh, M. and E. Hosseini, Intravascular leukocyte migration through platelet thrombi: directing leukocytes to sites of vascular injury. Thromb Haemost, 2015. 113(6): p. 1224–35.
- Gao, G., et al., Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis. BMC Cancer, 2020. 20(1): p. 179.
- Fogar, P., et al., Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas, 2006. 32(1): p. 22–8.
- Wangchinda, P. and S. Ithimakin, Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer. World J Surg Oncol, 2016. 14(1): p. 223.
- Ramos-Esquivel, A., L. Rodriguez-Porras, and J. Porras, Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in non-metastatic breast cancer patients from a Hispanic population. Breast Dis, 2017. 37(1): p. 1–6.
- Duan, J., L. Pan, and M. Yang, Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer: A meta-analysis. Medicine (Baltimore), 2018. 97(49): p. e13340.
- Al Jarroudi, O., et al., Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. Biomark Med, 2021. 15(14): p. 1289–1298.
- Guo, W., et al., Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals. Cancer Med, 2019. 8(9): p. 4135–4148.
- Hsieh, M.M., et al., Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med, 2007. 146(7): p. 486–92.
- Azab, B., M. Camacho-Rivera, and E. Taioli, Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One, 2014. 9(11): p. e112361.
- Zenan, H., et al., Clinical prognostic evaluation of immunocytes in different molecular subtypes of breast cancer. J Cell Physiol, 2019. 234(11): p. 20584–20602.
- Truffi, M., et al., Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2‒ Early Breast Cancer. Front Oncol, 2021. 11: p. 773078.
- Orditura, M., et al., Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis. ESMO Open, 2016. 1(2): p. e000038.
- Hu, R.J., et al., Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis. Clin Chim Acta, 2018. 484: p. 1–6.
- Patel, A.A. and S. Yona, Inherited and Environmental Factors Influence Human Monocyte Heterogeneity. Front Immunol, 2019. 10: p. 2581.
- Coates, S., et al., Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I Trials. Front Pharmacol, 2020. 11: p. 314.
- He, J., et al., Prognostic Significance of Preoperative Lactate Dehydrogenase to Albumin Ratio in Breast Cancer: A Retrospective Study. Int J Gen Med, 2023. 16: p. 507–514.
- Zhang, Y., Y. Sun, and Q. Zhang, Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis. Cancer Cell Int, 2020. 20: p. 224.
- Li, W., et al., Systemic Immune-Inflammation Index Is a Prognostic Factor for Breast Cancer Patients After Curative Resection. Front Oncol, 2021. 11: p. 570208.
- Wang, L., et al., Prognostic value of the systemic inflammation response index (SIRI) before and after surgery in operable breast cancer patients. Cancer Biomark, 2020. 28(4): p. 537–547.
- Hua, X., et al., The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer. Curr Probl Cancer, 2020. 44(4): p. 100560.
- Jiang, C., et al., The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Clin Breast Cancer, 2022. 22(5): p. 424–438.
- Guthrie, G.J., et al., The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol, 2013. 88(1): p. 218–30.
- Cho, U., et al., Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma. Biomedicines, 2022. 10(6).
- Noh, H., M. Eomm, and A. Han, Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer, 2013. 16(1): p. 55–9.
- Ethier, J.L., et al., Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res, 2017. 19(1): p. 2.
- Jia, W., et al., The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients. PLoS One, 2015. 10(11): p. e0143061.
- Kauffmann-Guerrero, D., et al., Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study. Sci Rep, 2021. 11(1): p. 10919.
- Wariss, B.R., et al., Effectiveness of four inflammatory markers in predicting prognosis in 2374 women with breast cancer. Maturitas, 2017. 101: p. 51–56.
- Gong, Z., et al., Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis. Int J Biol Markers, 2022. 37(4): p. 339–348.
- Onagi, H., et al., High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs. Breast Cancer Res, 2022. 24(1): p. 67.
- Olsson, A.K. and J. Cedervall, NETosis in Cancer - Platelet-Neutrophil Crosstalk Promotes Tumor-Associated Pathology. Front Immunol, 2016. 7: p. 373.
- Labelle, M., S. Begum, and R.O. Hynes, Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A, 2014. 111(30): p. E3053–61.
- Gonzalez-Aparicio, M. and C. Alfaro, Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role? J Immunol Res, 2019. 2019: p. 6252138.
- Ronchetti, L., et al., Neutrophil extracellular traps in cancer: not only catching microbes. J Exp Clin Cancer Res, 2021. 40(1): p. 231.
- Gerratana, L., et al., Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis. Sci Rep, 2020. 10(1): p. 7010.
- Liu, Y., et al., Relationship between lymphocyte to monocyte ratio and brain metastasis in non-smalll cell lung cancer patients. Am J Transl Res, 2022. 14(6): p. 3936–3945.
- Zergoun, A.A., et al., Plasma secretome analyses identify IL-8 and nitrites as predictors of poor prognosis in nasopharyngeal carcinoma patients. Cytokine, 2022. 153: p. 155852.
- Lu, X., et al., Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma. Eur J Cancer, 2011. 47(3): p. 339–46.
- Guo, H., et al., Knockdown of Notch1 inhibits nasopharyngeal carcinoma cell growth and metastasis via downregulation of CCL2, CXCL16, and uPA. Mol Carcinog, 2019. 58(10): p. 1886–1896.
- Jin, J., et al., CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment. Front Oncol, 2021. 11: p. 722916.
- Güç, E. and J.W. Pollard, Redefining macrophage and neutrophil biology in the metastatic cascade. Immunity, 2021. 54(5): p. 885–902.
- Kumar, V. and A. Sharma, Neutrophils: Cinderella of innate immune system. Int Immunopharmacol, 2010. 10(11): p. 1325–34.
- Rubenich, D.S., et al., Tumor-neutrophil crosstalk promotes in vitro and in vivo glioblastoma progression. Front Immunol, 2023. 14: p. 1183465.
- Bun, A., et al., Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes. Anticancer Res, 2020. 40(5): p. 2871–2880.